Pro Medicus Ltd
Pro Medicus Limited is an Australia-based healthcare informatics company.
The business
Pro Medicus Limited is an Australia-based healthcare informatics company. It provides a full range of medical imaging software and services to hospitals, imaging centers and health care groups in Australia, North America and Europe. Its products include Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro and Visage Ease. Visage RIS is a radiology information systems (RIS) medical software for practicing of management, training, installation and professional services. Visage RIS capabilities include patient registration, billing, scheduling, typing, HL7 integration, financial reporting, digital dictation and voice recognition integration. Visage 7.0 is a healthcare imaging software that provides clinicians with visualization capability for rapidly viewing two-Dimensional (2-D), 3-D and 4-D medical images and picture archive and communication system (PACS)/digital imaging software that is sold directly and to original equipment manufacturers, training, installation and others.
Small Caps Research
No research on Pro Medicus Ltd yet
We cover the ASX small-cap market one company at a time. Request coverage and we’ll prioritise PME based on demand.
Share price
Market Statistics
Valuation
Trading Activity
Performance
Latest news

Weekly wrap: Aussie shares sink 0.6% as US Bonds defy Bessent intervention
ASX slips 0.6% for the week as US yields rise despite Bessent's bid to push rates lower; property and tech slide, Zip plunges 15% amid inflation jitters.

Miners Rescue the War-Torn ASX Yet Again
Miners rescue ASX 200 as copper rally lifts Rio Tinto, BHP; Bravura soars on earnings; banks steady amid oil/war jitters.

Five New Stocks For The Healthcare Sector Rotation: PME, TLX, TNE, 360, and SDR
ASX healthcare rotation heats up as PME, TLX, TNE, 360, SDR emerge—five stocks positioned to ride the sector shift amid oil, inflation and volatility.

SmallCaps Weekly Wrap & New Fundie Picks
Looking for charts & signals? See the tab.
Unlock the full research library - free.
Create a free account to access every broker report, CEO interview, IPO alert, and daily market wrap. No credit card. No paywall.